Join
Live feed
·
NEWSReleasevia Quantisnow
Baudax Bio Inc. logo

BioCryst Pharmaceuticals Updated Its Agreement With Torii Pharmaceutica For ORLADEYO In Japan; BioCryst Japan K.K. Responsible For All Commercial Promotion Activities And Torii Will Be Responsible For Hereditary Angioedema Disease Awareness Activities

ByQuantisnow·Wall Street's wire, on your screen.
BXRX· Baudax Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BXRX (Baudax Bio Inc.) and more on Quantisnow.